PAYC vs. NBIX
PAYC (Paycom Software, Inc.) and NBIX (Neurocrine Biosciences, Inc.) are both stocks. PAYC operates in Software - Application (Technology), while NBIX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, PAYC returned 12.79%/yr vs 13.16%/yr for NBIX. At a 0.31 correlation, their price movements are largely independent.
Performance
PAYC vs. NBIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PAYC achieves a -15.13% return, which is significantly lower than NBIX's 12.64% return. Both investments have delivered pretty close results over the past 10 years, with PAYC having a 12.79% annualized return and NBIX not far ahead at 13.16%.
PAYC
- 1D
- 1.72%
- 1M
- -0.01%
- YTD
- -15.13%
- 6M
- -18.82%
- 1Y
- -45.87%
- 3Y*
- -24.70%
- 5Y*
- -16.50%
- 10Y*
- 12.79%
NBIX
- 1D
- -1.81%
- 1M
- -0.97%
- YTD
- 12.64%
- 6M
- 4.55%
- 1Y
- 27.80%
- 3Y*
- 18.64%
- 5Y*
- 10.13%
- 10Y*
- 13.16%
PAYC vs. NBIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PAYC Paycom Software, Inc. | -15.13% | -21.70% | -0.04% | -33.06% | -25.26% | -8.19% | 70.82% | 116.22% | 52.43% | 76.59% |
NBIX Neurocrine Biosciences, Inc. | 12.64% | 3.90% | 3.60% | 10.31% | 40.24% | -11.14% | -10.83% | 50.53% | -7.96% | 100.49% |
Correlation
The correlation between PAYC and NBIX is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Apr 15, 2014 | 0.31 |
Over the past year, the correlation between PAYC and NBIX has dropped to 0.05 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.
Fundamentals
PAYC:
$6.89B
NBIX:
$16.52B
PAYC:
$8.58
NBIX:
$6.53
PAYC:
15.68
NBIX:
24.46
PAYC:
0.59
NBIX:
0.48
PAYC:
3.52
NBIX:
5.27
PAYC:
8.49
NBIX:
4.85
PAYC:
$2.09B
NBIX:
$3.10B
PAYC:
$1.70B
NBIX:
$3.05B
PAYC:
$803.80M
NBIX:
$881.20M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PAYC vs. NBIX — Risk / Return Rank
PAYC
NBIX
PAYC vs. NBIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Paycom Software, Inc. (PAYC) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PAYC | NBIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.11 | ||
| Sortino ratioReturn per unit of downside risk | -3.23 | ||
| Omega ratioGain probability vs. loss probability | 0.78 | 1.19 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | 1.34 | -2.19 |
| Martin ratioReturn relative to average drawdown | -1.34 | 2.94 | -4.27 |
Loading charts...
Drawdowns
PAYC vs. NBIX - Drawdown Comparison
The maximum PAYC drawdown since its inception was -78.99%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for PAYC and NBIX.
Loading charts...
Drawdown Indicators
| PAYC | NBIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.99% | -97.21% | +18.22% |
Max Drawdown (1Y)Largest decline over 1 year | -53.59% | -20.90% | -32.69% |
Max Drawdown (3Y)Largest decline over 3 years | -68.70% | -42.89% | -25.81% |
Max Drawdown (5Y)Largest decline over 5 years | -78.99% | -42.89% | -36.10% |
Max Drawdown (10Y)Largest decline over 10 years | -78.99% | -46.39% | -32.60% |
Current DrawdownCurrent decline from peak | -75.06% | -4.54% | -70.52% |
Average DrawdownAverage peak-to-trough decline | -27.21% | -43.84% | +16.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.24% | 9.49% | +25.75% |
Volatility
PAYC vs. NBIX - Volatility Comparison
Paycom Software, Inc. (PAYC) has a higher volatility of 12.21% compared to Neurocrine Biosciences, Inc. (NBIX) at 9.63%. This indicates that PAYC's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PAYC | NBIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.21% | 9.63% | +2.58% |
Volatility (6M)Calculated over the trailing 6-month period | 30.11% | 23.91% | +6.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.80% | 31.38% | +6.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.48% | 32.73% | +11.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.50% | 39.13% | +5.37% |
Dividends
PAYC vs. NBIX - Dividend Comparison
PAYC's dividend yield for the trailing twelve months is around 1.12%, while NBIX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
PAYC Paycom Software, Inc. | 1.12% | 0.94% | 0.73% | 0.54% |
Financials
PAYC vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Paycom Software, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PAYC vs. NBIX - Profitability Comparison
PAYC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Paycom Software, Inc. reported a gross profit of 484.60M and revenue of 571.90M. Therefore, the gross margin over that period was 84.7%.
NBIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a gross profit of 800.70M and revenue of 814.50M. Therefore, the gross margin over that period was 98.3%.
PAYC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Paycom Software, Inc. reported an operating income of 210.20M and revenue of 571.90M, resulting in an operating margin of 36.8%.
NBIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported an operating income of 193.40M and revenue of 814.50M, resulting in an operating margin of 23.7%.
PAYC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Paycom Software, Inc. reported a net income of 155.70M and revenue of 571.90M, resulting in a net margin of 27.2%.
NBIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neurocrine Biosciences, Inc. reported a net income of 197.90M and revenue of 814.50M, resulting in a net margin of 24.3%.
Frequently Asked Questions
PAYC and NBIX have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PAYC has higher volatility (12.21%) compared to NBIX (9.63%). In terms of maximum drawdown, PAYC dropped -78.99% vs NBIX's -97.21%.
NBIX currently has the higher Sharpe Ratio (0.89 vs -1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PAYC and NBIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer